These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21030602)

  • 1. Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis.
    Crosbie EJ; Zwahlen M; Kitchener HC; Egger M; Renehan AG
    Cancer Epidemiol Biomarkers Prev; 2010 Dec; 19(12):3119-30. PubMed ID: 21030602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.
    Chang SC; Lacey JV; Brinton LA; Hartge P; Adams K; Mouw T; Carroll L; Hollenbeck A; Schatzkin A; Leitzmann MF
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):723-30. PubMed ID: 17416763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype.
    McCullough ML; Patel AV; Patel R; Rodriguez C; Feigelson HS; Bandera EV; Gansler T; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):73-9. PubMed ID: 18187388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What influence does hormone replacement therapy have on endometrial cancer risk?
    Barakat RR
    Nat Clin Pract Oncol; 2005 Nov; 2(11):546-7. PubMed ID: 16270092
    [No Abstract]   [Full Text] [Related]  

  • 5. [Modern tendencies in HRT of patients treated for endometrial cancer].
    Ivanov C
    Akush Ginekol (Sofiia); 2009; 48(2):20-2. PubMed ID: 20198772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.
    Wang Y; Jacobs EJ; Teras LR; Pavluck AL; Rodriguez C; Thun MJ; Calle EE
    Cancer Causes Control; 2007 Oct; 18(8):793-9. PubMed ID: 17619155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight history and risk of endometrial cancer among Chinese women.
    Xu WH; Xiang YB; Zheng W; Zhang X; Ruan ZX; Cheng JR; Gao YT; Shu XO
    Int J Epidemiol; 2006 Feb; 35(1):159-66. PubMed ID: 16258056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. For women on hormone therapy, other options may be safer.
    Brink S
    US News World Rep; 2000 Feb; 128(5):58. PubMed ID: 11184138
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement error does not explain the persistence of a body mass index association with endometrial cancer after adjustment for endogenous hormones.
    Potischman N; Gail MH; Troisi R; Wacholder S; Hoover RN
    Epidemiology; 1999 Jan; 10(1):76-9. PubMed ID: 9888284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical activity and risk of endometrial cancer: a population-based prospective cohort study.
    Friberg E; Mantzoros CS; Wolk A
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2136-40. PubMed ID: 17057024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for endometrial cancer in Turkish women: results from a hospital-based case-control study.
    Reis N; Beji NK
    Eur J Oncol Nurs; 2009 Apr; 13(2):122-7. PubMed ID: 19332387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol consumption, cigarette smoking, and endometrial cancer risk: results from the Netherlands Cohort Study.
    Loerbroks A; Schouten LJ; Goldbohm RA; van den Brandt PA
    Cancer Causes Control; 2007 Jun; 18(5):551-60. PubMed ID: 17437180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of hormone therapies on type I and II endometrial cancer: A nationwide cohort study.
    Mørch LS; Kjaer SK; Keiding N; Løkkegaard E; Lidegaard Ø
    Int J Cancer; 2016 Mar; 138(6):1506-15. PubMed ID: 26421912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of cardiovascular disease, cancer and death in postmenopausal women affirming use of hormone replacement therapy.
    Hedblad B; Merlo J; Manjer J; Engström G; Berglund G; Janzon L
    Scand J Public Health; 2002; 30(1):12-9. PubMed ID: 11928828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and endometrial carcinoma.
    Bjørge T; Stocks T; Lukanova A; Tretli S; Selmer R; Manjer J; Rapp K; Ulmer H; Almquist M; Concin H; Hallmans G; Jonsson H; Stattin P; Engeland A
    Am J Epidemiol; 2010 Apr; 171(8):892-902. PubMed ID: 20219764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case control study on risk factors of endometrial carcinoma in Tianjin].
    Hou Q; Wang QS; Wang JF
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jan; 29(1):30-2, 61. PubMed ID: 8033622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term alcohol consumption and risk of endometrial cancer incidence: a prospective cohort study.
    Friberg E; Wolk A
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):355-8. PubMed ID: 19124521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
    Magnusson C; Weiderpass E
    Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changing view of hormone replacement therapy.
    Vogel RA
    Rev Cardiovasc Med; 2003; 4(2):68-71. PubMed ID: 12776015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.